Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.530
-0.120 (-4.53%)
Mar 3, 2026, 4:00 PM EST - Market closed
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $568.57 million as of March 4, 2026. Its market cap has increased by 92.32% in one year.
Market Cap
568.57M
Enterprise Value
401.52M
1-Year Change
92.32%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $568.57M, a decrease of -80.26%. That is a compound annual growth rate of -19.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 595.53M | 93.43% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 641.07M |
| Replimune Group | 631.68M |
| Rigel Pharmaceuticals | 630.58M |
| Zura Bio | 628.08M |
| Lexicon Pharmaceuticals | 627.81M |
| Alto Neuroscience | 611.70M |
| MeiraGTx Holdings | 608.51M |
| LB Pharmaceuticals | 607.43M |